Business

Update re Notice of Annual General Meeting

Update re Notice of Annual General Meeting.

articleRua Life Sciences PlcAugust 13, 20213/company/rua-life-sciences-plc/news/update-re-notice-of-annual-general-meeting
Update re Notice of Annual General Meeting

About this update from Rua Life Sciences Plc

[{"type":"text","content":"\n \n \n \n RNS Number : 6468I\n RUA Life Sciences PLC\n 13 August 2021\n  \n \n \n \n 13 August 2021\n \n \n  \n \n \n  \n \n \n RUA Life Sciences plc\n \n \n (\"RUA\" or the \"Company\")\n \n \n  \n \n \n 2021 Notice of Annual General Meeting - Correction \n \n \n  \n \n \n RUA \n Life Sciences (AIM:RUA) , the holding company of a group of medical device businesses focused on the exploitation of the world's leading long-term implantable biostable polymer (Elast-EonTM),\n announces that resolution numbered 7 (\"Resolution 7\") set out in its Notice of 2021 Annual General Meeting (the \"Notice\") to be held on Tuesday 31 August 2021 (\"AGM\") contained certain typographical errors.  Resolution 7 refers to proposed authorities to allot (or grant rights over) new ordinary shares in the capital of RUA pursuant to either an open offer or a rights issue.  As set out in the explanatory notes to the Notice, the intention is that such authorities comply with the Investment Association's guidelines and be limited to an aggregate nominal value equal to (i) approximately 33% with regard to paragraph 7.1 of Resolution 7, and (ii) approximately 66% in relation to paragraph 7.2 of Resolution 7.  \n \n \n  \n \n \n Accordingly, the maximum number of new ordinary shares which may be allotted pursuant to (a) paragraph 7.1 should be equal to an aggregate nominal value of £369,746 (not £396,746 as currently stated), and (b) paragraph 7.2 should be equal to an aggregate nominal value of £739,492 (not £793,492 as currently stated).  A procedural resolution to approve such corrected Resolution 7 will be proposed at the AGM.  A copy of the corrected Notice is available to view in the \"Investor Relations\" section of RUA's website at \n \n https://rualifesciences.com/investor-relations/\n \n .  The corrected Notice is also available for inspection at RUA's registered office (c/o Davidson Chalmers Stewart LLP, 163 Bath Street, Glasgow, G2 4SQ, UK).  As these were clerical errors, no new Notice is required to be sent out to shareholders.\n \n \n  \n \n \n If shareholders have any questions in connection with the proposed business of the AGM, or the contents of this communication, they should email RUA's Company Secretary , Kate Full, at [email protected].\n \n \n...

More updates from Rua Life Sciences Plc